FIRST TRUST ADVISORS LP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 272 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$1,666,417
+233.0%
65,607
+431.7%
0.00%
+100.0%
Q4 2022$500,429
+21.2%
12,338
-1.3%
0.00%0.0%
Q3 2022$413,000
-6.1%
12,498
+30.7%
0.00%
Q1 2022$440,000
-75.5%
9,561
-66.7%
0.00%
-100.0%
Q3 2021$1,795,000
-22.1%
28,754
-17.3%
0.00%
-33.3%
Q1 2021$2,305,000
+19.3%
34,758
+38.0%
0.00%0.0%
Q4 2020$1,932,000
-33.9%
25,182
-62.9%
0.00%
-40.0%
Q3 2020$2,923,000
-12.0%
67,874
-11.8%
0.01%
-16.7%
Q2 2020$3,323,000
+31.6%
76,933
-12.3%
0.01%0.0%
Q1 2020$2,525,000
-80.3%
87,766
-56.6%
0.01%
-72.7%
Q4 2019$12,841,000
+221.8%
202,442
+43.0%
0.02%
+175.0%
Q3 2019$3,990,000
-13.2%
141,586
-18.4%
0.01%
-11.1%
Q2 2019$4,595,000
+741.6%
173,413
+482.3%
0.01%
+800.0%
Q1 2019$546,000
-75.4%
29,781
-83.3%
0.00%
-80.0%
Q4 2018$2,220,000178,7200.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders